Lincoln National officer Craig Beazer filed a Form 144 notice of proposed sale on November 9, 2026, disclosing plans to sell 17,980 shares of Lincoln National common stock through UBS Financial Services Inc.
CIBC Private Wealth Group LLC filed an amended beneficial ownership statement with the SEC on November 9, 2026, disclosing a 5.6% position in EVgo Inc.'s Common Class A shares as of the event date of November 5, 2026.
JPMorgan Chase Financial Company LLC filed a Free Writing Prospectus on November 9, 2026, disclosing the preliminary terms of two-year, non-callable-for-six-months Auto Callable Contingent Interest Notes linked to the Nasdaq-100, Russell 2000, and S&P 500 indexes, with a pricing date of November 24, 2026.
JPMorgan Chase Financial Company LLC filed a Free Writing Prospectus on November 9, 2026, disclosing terms for 3-year non-call 6-month Auto Callable Contingent Interest Notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of November 24, …
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) on November 9, 2026, disclosing terms for 2-year non-callable-for-six-months Auto Callable Contingent Interest Notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of November 30, …
JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 9, 2026, disclosing the preliminary terms of 18-month autocallable contingent interest notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of November 24, 2026.
JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 9, 2026, disclosing the preliminary terms of 3-year non-call 6-month auto callable contingent interest notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of …
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed Amendment No. 2 to a Schedule 13G with the SEC on October 8, 2026, disclosing zero beneficial ownership of Chart Industries, Inc. common stock as of September 30, 2026.
HSBC Holdings plc filed a Form 6-K on November 9, 2026, disclosing the purchase for cancellation of ordinary shares on UK venues and the Hong Kong Stock Exchange as part of the buy-back announced on October 28, 2026.
Coastlands Capital LP and related entities filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 852,669 shares of Sutro Biopharma, Inc. common stock, representing 5.14% of the outstanding class, as of a triggering event dated November 5, 2026.